Key regions: France, Europe, United Kingdom, Brazil, India
The demand for Oncology Drugs in Seychelles has been on the rise in recent years.
Customer preferences: Oncology drugs are medications used to treat cancer and its symptoms. The increasing prevalence of cancer in Seychelles has led to a growing demand for oncology drugs. Patients prefer drugs that are effective, have minimal side effects, and are affordable. The majority of patients prefer oral medications over intravenous chemotherapy due to the convenience they offer.
Trends in the market: The oncology drugs market in Seychelles is witnessing a shift towards targeted therapies. Targeted therapies are drugs that target specific proteins or genes that are found in cancer cells. These drugs are more effective and have fewer side effects compared to traditional chemotherapy. The use of immunotherapy is also on the rise in Seychelles. Immunotherapy is a type of cancer treatment that uses the body's immune system to fight cancer. This type of therapy is gaining popularity due to its effectiveness in treating various types of cancer.
Local special circumstances: Seychelles is a small island nation with a population of just under 100,000 people. The healthcare system in Seychelles is still developing, and patients often have to travel abroad to receive specialized medical treatment. This has led to an increase in medical tourism, with patients traveling to neighboring countries such as India and South Africa for cancer treatment.
Underlying macroeconomic factors: The Seychelles economy is heavily reliant on tourism, which has been severely impacted by the COVID-19 pandemic. This has led to a decline in government revenue and has limited the country's ability to invest in healthcare infrastructure. The high cost of oncology drugs is also a major challenge for patients in Seychelles, as most drugs have to be imported from abroad.In conclusion, the demand for oncology drugs in Seychelles is increasing due to the rising prevalence of cancer. Patients prefer drugs that are effective, have minimal side effects, and are affordable. The market is witnessing a shift towards targeted therapies and immunotherapy. However, the high cost of oncology drugs and limited healthcare infrastructure are major challenges that need to be addressed to ensure that patients have access to quality cancer treatment.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
